E2F1 and gastric cancer: In GC, a work published in 2008 found enhanced sensitivity to 5-FU in GC cell lines with ectopic upregulation of E2F1 and associated E2F1 immunopositivity to better prognosis in a cohort of GC patients receiving adjuvant 5-FU [145].